The Valley Desk

NCT05128825 · Interventional trial

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Overall registry status Recruiting

Phase 2

Conditions High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov